www.rp.pl · October 27, 2026
Rheumatic patients losing access to drug programmes, specialist warns
Many smaller centres are not enrolling patients with rheumatic diseases in drug programmes because of the healthcare crisis, Prof. Brygida Kwiatkowska of the NIGRiR institute in Warsaw told PAP. She says lack of proper treatment will shorten patients' lives by 10-15 years.